LifeStance Health Group, Inc.
LifeStance Health Group, Inc.
Your view on LFST
Overview
What the company does, where it operates, and who runs it.
About LifeStance Health Group, Inc.
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- David Patrick Bourdon
- Headquarters
- 4800 N. Scottsdale Road, Scottsdale, AZ, US
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- David Patrick Bourdon
- Headquarters
- 4800 N. Scottsdale Road, Scottsdale, AZ, US
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder.
In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for LifeStance Health Group, Inc., and the rating behind it. LFST last traded at $13.06, 100.5× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for LifeStance Health Group, Inc.. Starting points for LifeStance Health Group, Inc.: P/E 100.5, EPS $0.13, beta 1.24 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for LifeStance Health Group, Inc.. LifeStance Health Group, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for LifeStance Health Group, Inc.. Trailing twelve-month EPS for LifeStance Health Group, Inc. stands at $0.13. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for LifeStance Health Group, Inc.. LifeStance Health Group, Inc. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
LifeStance Health Group, Inc. valued side by side against its closest peers. LifeStance Health Group, Inc. is measured against Medical - Care Facilities peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold LifeStance Health Group, Inc., and how their positions are changing. At a $4.99B market value, institutional positions materially move LifeStance Health Group, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by LifeStance Health Group, Inc. executives and directors. Shares of LifeStance Health Group, Inc. have traded between $3.74 and $8.29 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming LifeStance Health Group, Inc.. LifeStance Health Group, Inc. is a $4.99B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming LifeStance Health Group, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for LifeStance Health Group, Inc.. Coverage tracks LifeStance Health Group, Inc. within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.